Afinitor / Votubia (Everolimus)
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 05/17/2019
Pipeline Type
Newly Marketed
Phase Of Development
Sponsors and Collaborators
Mechanism of Action
Mechanism Description
mTOR Inhibitor
Populations Tested In
Other Resources
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Location of Clinical Trials
Clinical Trial link